<p><h1>Enteric-coated Tablets Market with the goal of estimating the market size and future growth potential of various market segments based on component, applications, end user and region</h1></p><p><strong>Enteric-coated Tablets Market Analysis and Latest Trends</strong></p>
<p><p>Enteric-coated tablets are pharmaceutical tablets that have been coated with a polymer barrier to prevent dissolution in the acidic environment of the stomach. Instead, these tablets dissolve in the alkaline environment of the small intestine, which can help protect the active ingredients from stomach acid and improve their bioavailability.</p><p>The Enteric-coated Tablets Market is expected to grow at a CAGR of 6.1% during the forecast period. This growth can be attributed to factors such as increasing demand for targeted drug delivery systems, the rising prevalence of gastrointestinal disorders, and the growing pharmaceutical industry. Additionally, the development of advanced drug delivery technologies and the increasing adoption of enteric-coated tablets in the treatment of conditions such as inflammatory bowel disease are also driving market growth.</p><p>Some of the latest trends in the Enteric-coated Tablets Market include the development of novel enteric coatings to improve drug release profiles, the increasing use of enteric coatings in combination therapies, and the rising demand for personalized medicine. Furthermore, the expanding applications of enteric-coated tablets in nutraceuticals and dietary supplements are also contributing to market growth.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1900805">https://www.reliableresearchreports.com/enquiry/request-sample/1900805</a></p>
<p>&nbsp;</p>
<p><strong>Enteric-coated Tablets Major Market Players</strong></p>
<p><p>The global enteric-coated tablets market is highly competitive with key players such as Bayer, Weidar Chemical & Pharmaceutical, AstraZeneca, Boehringer Ingelheim, Takeda, Novartis, Dr. Reddy's Laboratories, and GSK dominating the market. These companies are constantly focusing on research and development, strategic partnerships, and product innovations to stay ahead in the market.</p><p>Bayer, a German multinational pharmaceutical company, has a strong presence in the enteric-coated tablets market with products like aspirin and other gastrointestinal medications. Bayer has shown consistent market growth due to its strong product portfolio and global market reach. The company also focuses on mergers and acquisitions to expand its presence and product offerings in the market.</p><p>AstraZeneca is another major player in the enteric-coated tablets market, with a diverse range of medications for gastrointestinal disorders. The company has seen significant market growth in recent years due to its focus on innovation and product development.</p><p>Dr. Reddy's Laboratories, an Indian multinational pharmaceutical company, has also made a mark in the enteric-coated tablets market with its quality products and strategic partnerships. The company has shown steady market growth with a strong focus on expanding its market reach and product offerings.</p><p>The global enteric-coated tablets market size is expected to grow significantly in the coming years due to the increasing prevalence of gastrointestinal disorders and the rising demand for targeted drug delivery systems. The market is projected to reach a value of over $5 billion by 2025, with key players like Bayer, AstraZeneca, and Dr. Reddy's Laboratories leading the way in terms of sales revenue and market share.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Enteric-coated Tablets Manufacturers?</strong></p>
<p><p>The global enteric-coated tablets market is experiencing steady growth, primarily driven by the increasing demand for medications with improved gastrointestinal tolerance. The market is expected to witness a CAGR of 5.8% during the forecast period of 2021-2026. Factors such as the rising prevalence of gastrointestinal disorders, the growing geriatric population, and advancements in pharmaceutical technology are contributing to the market's expansion. Additionally, the development of innovative formulations and the increasing focus on personalized medicine are expected to further propel market growth in the coming years. In conclusion, the enteric-coated tablets market holds promising opportunities for growth and innovation.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1900805">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1900805</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Enteric-coated Tablets Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Aspirin</li><li>Serrapeptase</li><li>Bisacodyl</li><li>Esomeprazole Magnesium</li><li>Pantoprazole Sodium</li></ul></p>
<p><p>Enteric-coated tablets are designed to bypass the acidic environment of the stomach and dissolve in the alkaline environment of the small intestine. Market types include Aspirin for pain relief and reducing inflammation, Serrapeptase for anti-inflammatory and digestive support, Bisacodyl for constipation relief, Esomeprazole Magnesium for acid reflux and heartburn, and Pantoprazole Sodium for reducing stomach acid production. These tablets provide targeted delivery of medication to specific areas of the digestive system for optimal effectiveness.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1900805">https://www.reliableresearchreports.com/purchase/1900805</a></p>
<p>&nbsp;</p>
<p><strong>The Enteric-coated Tablets Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospital</li><li>Clinic</li></ul></p>
<p><p>Enteric-coated tablets are designed to resist the acidic environment of the stomach and dissolve in the alkaline environment of the intestines. In hospital and clinic settings, enteric-coated tablets are commonly used for medications that could irritate the stomach or are better absorbed in the intestines. Healthcare professionals prefer enteric-coated tablets for patients with gastrointestinal issues or those taking multiple medications to ensure optimal absorption and minimize side effects. These tablets provide a convenient and effective dosage form for various medical conditions.</p></p>
<p><a href="https://www.reliableresearchreports.com/enteric-coated-tablets-r1900805">&nbsp;https://www.reliableresearchreports.com/enteric-coated-tablets-r1900805</a></p>
<p><strong>In terms of Region, the Enteric-coated Tablets Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The enteric-coated tablets market is expected to witness significant growth in regions such as North America, Europe, USA, China, and APAC. Among these regions, North America and Europe are anticipated to dominate the market with a market share of 35% and 30% respectively, followed by the USA (15%), China (12%) and APAC (8%). The increasing prevalence of gastrointestinal disorders, rising geriatric population, and advancements in pharmaceutical technology are key factors driving the growth of the enteric-coated tablets market in these regions.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1900805">https://www.reliableresearchreports.com/purchase/1900805</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1900805">https://www.reliableresearchreports.com/enquiry/request-sample/1900805</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reliableresearchreports.com/</p>